Armed with an asset that could be an improvement on Pfizer’s blockbuster smoking cessation drug Chantix/Champix (varenicline) ...

Two existing medications commonly used for combating smoking and depression can be used together to effectively treat alcohol ...

Results Users of varenicline were younger, reported more time spent with urges to smoke at baseline, and were less likely to stop abruptly during their last quit attempt (all p < 0.01).

Both varenicline and nicotine replacement therapy (NRT) help achieve smoking cessation. However, limited evidence exists regarding whether combination of varenicline and NRT is more effective than ...

Results showed the greatest reduction in alcohol consumption among those who received the combination therapy. Varenicline alone also produced a measurable effect. The outcomes were assessed using ...

Smoking cessation treatments such as varenicline and bupropion carry psychiatric warnings and offer modest long-term quit rates. SKNY-1 was designed to overcome these limitations. It selectively ...

To do so, they recruited 384 individuals for a randomized, double-blind, placebo-controlled trial in Sweden. Patients were an average age of 57 years and had moderate-to-severe alcohol use disorder.

The study, "Efficacy and safety of varenicline and bupropion, in combination and alone, for alcohol use disorder: a randomized, double-blind, placebo-controlled multicentre trial," was carried out ...

A daily pill that helps people stop smoking is to be offered by the NHS in England once again after it was withdrawn from sale in 2021 due to quality issues. A new generic version of varenicline ...

Healthcare professionals typically prescribe a 12-week supply of varenicline pills to people who want to quit smoking. In some cases, a person may receive a second 12-week prescription.